Microsoft Corporation MSFT co-founder Bill Gates expressed optimism on the efficacy of COVID-19 vaccines made by various drugmakers in an interview with CNN on Sunday.
What Happened: The billionaire told CNN’s Fareed Zakaria that while vaccines from Pfizer Inc PFE and Moderna Inc MRNA have already shown effectiveness against COVID-19 in early data, he expects similar results from AstraZeneca Plc AZN, Johnson & Johnson JNJ and Novavax, Inc NVAX vaccines.
“I'm optimistic that by February, it's very likely they'll all prove very efficacious and safe,” said Gates.
The tech billionaire expects the vaccine to “start to cut the numbers down” in spring.
Pfizer and its German partner BioNTech SE BNTX filed for emergency use authorization on Friday.
The vaccine made by the duo could reportedly be available for the high-risk populations in the United States by the middle or end of December.
Moderna is also expected to file for EUA soon and has released its interim Phase 3 results.
AstraZeneca’s vaccine was found to trigger similar immune responses in both young and elderly patients, as per findings of a phase two trial.
Older adults and people with pre-existing conditions are at the greatest risk of developing serious symptoms of COVID-19, according to the co-author of the phase two study, Dr. Maheshi Ramasamy.
Gates' foundation has backed the development of a vaccine for COVID-19 and said its entire focus was on fighting the pandemic.
Price Action: On Friday, Pfizer shares closed 1.41% higher at $36.70, Moderna Shares closed 5.22% higher at $97.61, AstraZeneca shares closed 2.35% higher at $55.30, Novavax shares closed 0.17% higher at $86.55, and Johnson & Johnson shares closed 0.53% lower at $146.36.
Photo courtesy: UK Department for International Development via Flickr
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.